I[NTRODUCTION]{.smallcaps} {#sec1-1}
==========================

Periodontal disease is a chronic polymicrobial infection affecting periodontal tissues. Chronic periodontitis is one of the very common chronic diseases worldwide, and is caused mainly by gram-negative anaerobic bacteria.\[[@ref1]\] This disease is associated with the accumulation of microflora at the dentogingival margin, although the causal relationship of specific organisms is not fully clear. It is believed that host bacterial interactions are responsible for the destruction of host periodontal tissues, and they lead to clinical manifestations of the disease.\[[@ref1]\]

The host tissue responds to the microbial challenge by generating inflammatory cell infiltrate in the tissue subjacents. Periodontal inflammation may not be limited to periodontal tissues, but it is well documented that periodontal diseases can affect systemic ailments, including adverse pregnancy outcomes.\[[@ref1]\]

Periodontal diseases experience frequent bacteremia resulting in the colonization of specific organisms or their products in uterine cavity.\[[@ref2]\] Bacteria associated with periodontal disease are not dissimilar to those known to be associated with genitourinary bacterial infections and adverse pregnancy outcomes. Many studies have shown the translocation of *Fusobacterium nucleatum*, *Prevotella nigrescens*, *Prevotella intermedia*, *Porphyromonas gingivalis*, and *Treponema denticola* to the feto-placental unit, whereby a maternal or fetal response has been shown, resulting in premature birth or low birth weight.\[[@ref2][@ref3]\] Since then more attention has been focused on oral infections and their effects on pregnancy.

Preeclampsia is a maternal syndrome characterized by proteinuria and hypertension and involves multi-organ tissue destruction and has become one of the main causes of maternal and fetal mortality.\[[@ref4]\] Many authors have postulated that periodontal disease is a possible risk factor for complications in pregnancy, including preeclampsia.\[[@ref5][@ref6]\] However, this association has yet to be proved.\[[@ref7]\]

This study was aimed at the identification of microflora (viral and bacterial) in subgingival and placental samples of pregnant women with preeclampsia with and without periodontal disease, and to coincide their percentages in subgingival plaque samples and placental samples to check the presence or absence of periodontal microbial involvement in placental tissues.

M[ATERIALS AND]{.smallcaps} M[ETHODS]{.smallcaps} {#sec1-2}
=================================================

The proposed study design was approved by the Institutional Ethics Committee, Narayana Dental College and Hospital with reference number Rc. no. ndc/pg/2015--16/ec/2015/01. Women attending prenatal checkups in Narayana Medical College and Hospital were screened for the study. After obtaining written consents, 200 preeclamptic subjects who met the eligibility criteria were recruited and categorized into two groups based on the presence and absence of chronic periodontitis: Group 1 (women with preeclampsia with periodontal disease, *n* = 100) and Group 2 (women with preeclampsia without periodontal disease, *n* = 100). Clinical parameters such as plaque index, bleeding on probing, probing depth, and clinical attachment level were recorded. Quantification of periodontopathic bacteria *P. gingivalis*, *P. intermedia*, *F. nucleatum*, and *Tannerella forsythia* and viruses such as herpes simplex virus (HSV), Epstein--Barr virus (EBV) and human cytomegalovirus (HCMV) were detected in subgingival samples at one point of time and later compared in placental tissue after parturition using 16S ribosomal ribonucleic acid (rRNA)-based real-time polymerase chain reaction (RT-PCR).

S[AMPLE COLLECTION AND STORAGE]{.smallcaps} {#sec2-1}
-------------------------------------------

The sampling site was isolated using cotton rolls, and supragingival plaques were removed with the help of sterile cotton, collected using sterile Gracey curette, and suspended in 100 μL of Tris--HCl buffer. The samples were immediately incubated at 50°C for 10min and then stored at -20°C freezer till further processing.

Placental samples were also collected and stored for the same patients and stored as aforementioned.

All the plaque samples and placental samples were subjected to PCR, which was carried out at advanced research center (Narayana Medical Institutions, Nellore, Andhra Pradesh, India).

M[ATERIALS]{.smallcaps} {#sec2-2}
-----------------------

Tris EDTA (TE) buffer (pH 8.0)10% SDSProteinase KPhenol--chloroform mixture5 M sodium acetate (pH 5.2)Isopropanol70% ethanol2 mL Eppendorf tubesMicropipette: 1--10 µL, 20--100 µL, and 200--1000 µLMicrotips: 1--10 µL, 20--100 µL, and 200--1000 µLMicro-centrifuge×10 Luna Universal quantitative polymerase chain reaction Master Mix (contains deoxynucleoside triphosphate (dATP, dTTP, dCTP, and dGTP; MgCl~2~; Taq buffer; SYBR Green; polymerase enzyme)

I[SOLATION OF DEOXYRIBONUCLEIC ACID FROM PLAQUE SAMPLES]{.smallcaps} {#sec2-3}
--------------------------------------------------------------------

Samples from deep freezer (-80°C) were allowed to thaw at room temperature.Plaque samples in microcentrifuge tubes were centrifuged at 10,000rpm for 5 min.A total of 875 µL of TE buffer was added to the pellet and resuspended in the buffer by gentle mixing.A total of 100 µL of 10% SDS and 5 µL of Proteinase K were added to the cells.The aforementioned mixture was mixed well and incubated at 37°C for 1h in incubator. A total of 1mL of phenol--chloroform mixture (3:1) was added to the contents, mixed well by inverting, and incubated at room temperature for 5 min and centrifuged at 10,000rpm for 10min at 4°C.The highly viscous jellylike supernatant was collected using Q-tips and was transferred to a fresh tube.The process was repeated once again with phenol--chloroform mixture, and the supernatant was collected in a fresh tube.A total of 100 µL of 5 M sodium acetate was added to the contents and was mixed gently.A total of 2 mL of isopropanol was added and mixed gently by inversion till white strands of DNA precipitates out, and it was centrifuged at 5000rpm for 10min.The supernatant was removed and 1ml 70% ethanol was added and again centrifuged at 10,000rpm for 10min. After air-drying for 5 min, 200 µL of TE buffer or distilled water was added to the pellet.

I[SOLATION OF DEOXYRIBONUCLEIC ACID FROM PLACENTAL SAMPLES]{.smallcaps} {#sec2-4}
-----------------------------------------------------------------------

Samples from deep freezer (-80°C) were allowed to thaw at room temperature.After thawing, placental tissues were homogenized by standard protocol with homogenizer. Homogenized samples were added with 100 µL of lysis buffer and 100 µL of 10% SDS and 5 µL of Proteinase K solution.The aforementioned mixture was mixed well and incubated at 37°C for 1h in incubator. A total of 1mL of phenol--chloroform mixture (3:1) was added to the contents, mixed well by inverting, and incubated at room temperature for 5 min.The contents were centrifuged at 10,000rpm for 10min at 4°C.The highly viscous jellylike supernatant was collected using Q-tips and was transferred to a fresh tube.The process was repeated once again with phenol--chloroform mixture, and the supernatant was collected in a fresh tube.A total of 100 µL of 5 M sodium acetate was added to the contents and was mixed gently.A total of 2 mL of isopropanol was added and mixed gently by inversion till white strands of DNA precipitates out, and it was centrifuged at 5000rpm for 10min.The supernatant was removed and 1mL 70% ethanol was added and centrifuged at 10,000rpm for 10min.After air-drying for 5 min, 200 µL of TE buffer was added to the pellet.

M[EASUREMENT OF DEOXYRIBONUCLEIC ACID CONCENTRATION]{.smallcaps} {#sec2-5}
----------------------------------------------------------------

The concentration of DNA was determined using a NanoDrop (Thermo Scientifics, Waltham, Massachusetts, USA) spectrophotometer at 260/280nm. The remaining samples were stored for PCR experiment.

This procedure was used to determine the amount, concentration, and purity of the DNA sample. Turn on the NanoDrop, click on ultraviolet (UV) measure option in NanoDrop software. Take 1 µL TE buffer to measure blank. Measure all the DNA samples (1 µl) separately.

The quality and yield obtained was measured by using a NanoDrop spectrophotometer. Quantitation of DNA was carried out of 1 µl of all plaque DNA samples using NanoDrop 2000/2000c spectrophotometers at absorbance at 260 and 280nm. The quality and yield obtained was measured by the ratio of 260 and 280nm using a NanoDrop spectrophotometer.

P[OLYMERASE CHAIN REACTION PROCEDURE]{.smallcaps} {#sec2-6}
-------------------------------------------------

All the mix was prepared in hard-shell PCR plate 96 well WHT-CLR (cat. no. HSP 9601) (Bio-Rad Laboratories, Hyderabad, Telangana, India) with seal plates of optically transparent film (Bio-Rad Laboratories). Care was taken to seal the plate edges and corners to prevent artifacts caused by evaporation. PCR amplification was performed in a real-time thermocycler (Bio-Rad-CFX100; Bio-Rad Laboratories). SYBR Green channel of the real-time instrument Bio-Rad-CFX100 (Bio-Rad Laboratories) was used for the quantification of *P. gingivalis* using Luna Universal Master Mix.

Putative periodontopathic bacteria (*P. gingivalis*, *F. nucleatum*, *P. intermedia*, *T. forsythia*, and *T. denticola*) were detected using 16S rRNA-based PCR. The primers of these microorganisms were designed based on the relevant literature and National Center for Biotechnology Information Basic Local Alignment Search Tool (BLAST) and then synthesized by Bioserve Biotechnologies and IRA Biotech, Hyderabad, Telangana, India. Primer sequences are shown in [Table 1](#T1){ref-type="table"}.

###### 

Comparison of virus in both subgingival plaque and placental samples within Groups

  Microbes                     Subgingival samples   Placental samples                                      
  ---------------------------- --------------------- ------------------- ------------ ---------- ---------- ---------
  Epstein--Barr virus          79 (79%)              20 (20%)            \<0.0001\*   10 (40%)   5 (20%)    0.123
  Human cytomegalovirus        8 (8%)                2 (3%)              0.052        2 (8%)     2 (3%)     1.00
  Herpes simplex virus         6 (6%)                2 (2%)              0.149        8 (32%)    2 (8%)     0.034\*
  *Porphyromonas gingivalis*   88 (88%)              48 (48%)            \<0.0001\*   16 (64%)   4 (16%)    0.001\*
  *Fusobacterium nucleatum*    83 (83%)              45 (45%)            \<0.0001\*   13 (52%)   10 (40%)   0.395
  *Prevotella intermedia*      68 (68%)              58 (58%)            0.143        16 (64%)   12 (48%)   0.255
  *Tannerella forsythia*       91 (91%)              79 (79%)            0.0175\*     14 (56%)   5 (20%)    0.009\*
  *Treponema denticola*        56 (56%)              25 (25%)            \<0.0001\*   12 (48%)   10 (40%)   0.569

\*Significant

Luna Universal qPCR Master Mix and other reaction components were kept at room temperature to set them at room temperature, and then placed on ice. After thawing completely, all reagents were mixed by inversion, pipetting, or gentle vortexing.

R[EACTION SETUP]{.smallcaps} {#sec2-7}
----------------------------

  Component                        25 µL reaction   Final concentration
  -------------------------------- ---------------- ---------------------
  Luna Universal qPCR Master Mix   10 µL            ×1
  Forward primer (10 µM)           1 µL             0.4 µM
  Reverse primer (10 µM)           1 µL             0.4 µM
  Template DNA                     Variable         \<100 ng
  Nuclease-free water              Up to 25 µL      

For each batch of samples, negative control was set for PCR amplification using sterile deionized water. Duplicates were performed for all samples.

The reaction conditions of *P. gingivalis*, *F. nucleatum*, and *T. forsythia* were as follows: initial denaturation at 94°C for 5 min, followed by 30 cycles of denaturation at 94°C for 30s, annealing at 55°C for 30s, and extension at 72°C for 30s, with a last extension at 72°C for 5 min.

The reaction conditions of *P. intermedia* and *T. denticola* were as follows: initial denaturation at 94°C for 3min, followed by 30 cycles of denaturation at 94°C for 30s, annealing at 55°C for 30s, and extension at 72°C for 20s, with a last extension at 72°C for 5 min.

The relative quantification of bacterial load was achieved by comparison with a standard amplification curve obtained from the (standard) genomic DNA corresponding to 6 × 10^6^ colony forming units (CFUs) of bacterial pure cultures. The standard bacterial DNA concentrations are 1 × 109, 1 × 107, 1 × 105, 1 × 103, and 1 × 101, respectively. Finally, the expected amplicon was analyzed along with standard 1kb DNA ladder on 1.5% agarose gel under UV transillumination.

R[ESULTS]{.smallcaps} {#sec1-3}
=====================

[Table 1](#T1){ref-type="table"} shows that high levels of microbes were observed both in subgingival and placental samples of Group 1 subjects compared to those in Group 2.

S[TATISTICAL ANALYSIS]{.smallcaps} {#sec2-8}
----------------------------------

The descriptive statistics (mean, standard deviation, or percentage) of all variables were recorded. Chi-square tests or two sample *t* tests were performed to compare differences in periodontal clinical parameters and the prevalence of periodontopathic microorganisms between the case group and the control group. The quality and yield obtained was measured by using a NanoDrop spectrophotometer. The NanoDrop data given mean DNA yield obtained was 120ng/µL (range, 51--225ng/µL) and purity (A260/A280 ratios) ranged between 1.55 and 1.90.

P[OLYMERASE CHAIN REACTION DATA ANALYSIS]{.smallcaps} {#sec2-9}
-----------------------------------------------------

In our approach, each bacterial species was targeted by individual qPCR reactions containing specific primer pairs. PCR experiment with primers of putative periodontopathic bacteria (*P. gingivalis*, *F. nucleatum*, *P. intermedia*, *T. forsythia*, and *T. denticola*) and viruses were performed by amplifying the 16S rRNA gene set up with the extracted genomic DNA from each sample. RT-PCR experiment using serial diluted templates over four orders of magnitude indicate the absence of PCR inhibitors in the extracted DNA.

The RT-PCR using the SYBR Green chemistry was applied to the clinical plaque samples, which has been described in "Methods" section. The original 10 µL of extracted DNA samples was run in the assay. The 16S rRNA gene in the plaque samples was evaluated by the SYBR Green assay using the standard of the DNA of each bacteria.

In our approach, each microbial species was targeted by individual qPCR reactions containing specific primer pairs. The Bio-Rad CFX96 software computed the *Ct* values that were compared with the *Ct* inferred from the amplification curve of a standard sample containing genomic DNA equivalent to 6 × 10^6^ CFUs of each microorganism. The target amplicon corresponding to *P. gingivalis* has 404 basepair lengths, *F. nucleatum* has 817 basepair length, *P. intermedia* has 259 basepair length, *T. forsythia* has 641 basepair length, and *T. denticola* has 314 basepair lengths. This feature could impact the amplification efficiency due to their increased size that enhances the assay sensitivity. However *Ct* values estimated in the early cycles were adequately comparable for the study's purpose.

[Table 1](#T1){ref-type="table"} shows that Group 1 subjects have more bacterial and viral counts compared to Group 2 subjects.

D[ISCUSSION]{.smallcaps} {#sec1-4}
========================

Periodontal diseases are initiated with microflora including bacteria and viruses. It is believed that host tissue damage is mediated by inflammatory response of the host.\[[@ref1]\] This inflammatory response may not be limited to the periodontal tissues but may induce systemic response by either microbes or their endotoxins in the systemic circulation, which may induce pro-inflammatory cytokine production. These cytokines then further activate the inflammatory response, which results in a chronic low-grade systemic upregulation of the inflammatory cytokines (such as interleukin \[IL\]-6, tumor necrosis factor (TNF)-α, and C-reactive protein) that further induce systemic activation of the inflammatory response and upregulate chronic low-grade systemic inflammation.

Cota LO *et al.*\[[@ref8]\] have postulated that the host response to a long-term exposure of periodontal pathogens may provoke systemic maternal and placental pro-inflammatory endothelial activation and dysfunction, representing a significant risk for vascular diseases (such as preeclampsia) and premature rupture of membranes, posing a threat to fetal--placental unit. Many studies evidenced fetal antibody seropositivity to oral organisms and exposure of fetus to these organisms or their end products. And it has been identified that fetal seropositivity to oral organisms is more frequently associated with preterm babies. These findings point to a blood-borne infectious pathway leading to direct fetal exposure as a major pathogenic mechanism of periodontitis associated with prematurity.\[[@ref3][@ref9],[@ref10]\]

Bacteria associated with periodontal disease are not dissimilar to those known to be associated with genitourinary bacterial infections and adverse pregnancy outcomes. Many studies have shown the translocation of *F. nucleatum*, *P. nigrescens*, *P. intermedia*, *P. gingivalis*, and *T. denticola* to the feto-placental unit, whereby a maternal or fetal response has been detected, resulted in premature birth or low birth weight.\[[@ref9]\]

The primary outcome of this study was more number of both bacteria (*T. forsythia*, *T. denticola*, *Porphyromonas gingivalis*, *Prevotella intermedia*, and *F. nucleatum*) and viruses (EBV, CMV, and HSV) in both subgingival plaque and placental samples in preeclamptic chronic periodontitis (Group 1) compared to women with preeclampsia without periodontal disease (Group 2).

The role of subgingival microbiota in the development of periodontal diseases has been extensively documented. More frequently higher levels of *Actinobacillus actinomycetemcomitans*, *P. gingivalis*, *T. forsythia*, and *T. denticola* are observed in periodontitis sites.\[[@ref1]\] A periodontal microbe, *F. nucleatum*, has been linked with adverse pregnancy outcomes.\[[@ref2]\] Many inflammatory markers such as C-reactive protein, IL-1, 6, and TNF-α markers of systemic inflammation are associated with periodontal disease. Therefore, these chemical mediators might be responsible intermediaries in developing adverse pregnancy outcomes.\[[@ref10]\] In addition, increased gingival bleeding due to hormonal influence will aid in the entry of bacteria into the blood stream, which may enter uterus.\[[@ref10][@ref11]\]

A 5-year prospective study showed that periodontal disease is significantly associated with a higher prevalence rate of preterm births. Authors found 2.9-fold higher rate of immunoglobulin M seropositivity for one or more organisms of the Orange or Red complex in preterm babies compared to term babies.\[[@ref12]\]

The secondary outcome of this research was that chronic periodontitis acts as a risk factor in patients with preeclampsia during pregnancy. This was well discussed in a recent review that bacterial pathogens, antigens, endotoxins, and pro-inflammatory cytokines produced during periodontal disease can cross the placental barrier, resulting in maternal-fetal unit disturbance, which could contribute to immune and inflammatory changes during pregnancy and might contribute to adverse pregnancy outcomes such as preterm low-birth weight.\[[@ref13]\]

The strength of this study was that it was designed in a large group of subjects. In scientific studies, sample size is a crucial consideration for quality research. In terms of statistics, larger sample size provides accurate mean values and allows the researcher to obtain better data determination and avoid errors. The limitation of the study would be that the samples were recruited from single center (Narayana Medical College and Hospital). From the current research, future research directions to be taken into consideration would be as follows: (1) studies in this relevance were suggested to be performed in multiple centers and (2) studies to be performed with large sample size, to reduce the center-based bias and errors.

C[ONCLUSION]{.smallcaps} {#sec1-5}
========================

Evidence of periodontopathic microflora in placental tissue proves that there is definite dissemination of periodontal microflora (bacteria and virus) through blood. This research strengthens the analysis of previous studies, mentioning chronic periodontitis as an individual risk factor during pregnancy and an additional risk factor in preeclampsia. This is thought to be due to the systemic dissemination of periodontal infection, and the chemical mediators thus released would play a major role in the pathogenesis of adverse pregnancy outcomes.
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